Compounds > dapsone

dapsone and chloroquine diphosphate

dapsone has been researched along with chloroquine diphosphate in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (16.67)	18.7374
1990's	1 (16.67)	18.2507
2000's	1 (16.67)	29.6817
2010's	3 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bacon, PA; Dawes, PT; Fowler, PD; Grindulis, KA; Scott, DL; Shadforth, M	1
Hatta, N; Imai, T; Sakai, H; Takata, M; Takehara, K; Tsutsui, K	1
Brandão, MAF; Ferreira, AO; Patrício, FB; Polonini, HC; Raposo, NRB; Silva, SL	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Andricopulo, AD; Moda, TL; Montanari, CA	1

Trials

1 trial(s) available for dapsone and chloroquine diphosphate

Article	Year
Anti-rheumatic drugs and joint damage in rheumatoid arthritis. The Quarterly journal of medicine, 1985, Volume: 54, Issue:213 Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Auranofin; Aurothioglucose; Blood Sedimentation; Chloroquine; Dapsone; Female; Gold Sodium Thiomalate; Humans; Male; Middle Aged; Penicillamine; Radiography; Time Factors	1985

Other Studies

5 other study(ies) available for dapsone and chloroquine diphosphate

Article	Year
Widespread pruritic plaques in a patient with subacute cutaneous lupus erythematosus and hypocomplementemia: response to dapsone therapy. Journal of the American Academy of Dermatology, 1996, Volume: 35, Issue:2 Pt 2 Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Complement C3; Complement System Proteins; Cyclosporine; Dapsone; Dermatologic Agents; Female; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Methylprednisolone; Prednisolone; Pruritus; Skin Diseases, Papulosquamous	1996
Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend(®) SF PH4 oral suspensions. Journal of pharmaceutical and biomedical analysis, 2016, Jan-25, Volume: 118 Topics: Administration, Oral; Amlodipine; Chloroquine; Chromatography, High Pressure Liquid; Dapsone; Drug Stability; Drug Storage; Feasibility Studies; Hydrogen-Ion Concentration; Isoxazoles; Phenytoin; Pyridoxine; Sulfadiazine; Sulfasalazine; Suspensions; Tetracycline; Trimethoprim; Zonisamide	2016
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007